-
-
[1] Gesta S, Tseng YH, Kahn CR. Developmental origin of fat:tracking obesity to its source[J]. Cell, 2007, 131:242-256. doi: 10.1016/j.cell.2007.10.004 [2] Poulton A, Nanan R. Drugs for the treatment of obesity[J]. JAMA, 2014, 311:1807. [3] Balsan GA, Vieira JL, De Oliveira AM, et al. Relationship between adiponectin, obesity and insulin resistance[J]. Rev Assoc Med Bras, 2015, 61:72-80. doi: 10.1590/1806-9282.61.01.072 [4] Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes[J]. J Biol Chem, 1995, 270:26746-26749. doi: 10.1074/jbc.270.45.26746 [5] Li RC, Krishnamoorthy P, Derohannessian S, et al. Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors[J]. Clin Exp Dermatol, 2014, 39:19-24. doi: 10.1111/ced.12250 [6] Obeid S, Hebbard L. Role of adiponectin and its receptors in cancer[J]. Cancer Biol Med, 2012, 9:213-220. https://www.ncbi.nlm.nih.gov/pubmed/23691481 [7] Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity[J]. J Biol Chem, 2004, 279:12152-12162. doi: 10.1074/jbc.M311113200 [8] Yamauchi T, Nio Y, Maki T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions[J]. Nat Med, 2007, 13:332-339. doi: 10.1038/nm1557 [9] Kahn BB, Alquier T, Carling D, et al. AMP-activated protein kinase:ancient energy gauge provides clues to modern understanding of metabolism[J]. Cell Metab, 2005, 1:15-25. doi: 10.1016/j.cmet.2004.12.003 [10] Tsuchida A, Yamauchi T, Takekawa S, et al. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue:comparison of activation of PPARalpha, PPARgamma, and their combination[J]. Diabetes, 2005, 54:3358-3370. doi: 10.2337/diabetes.54.12.3358 [11] Matsunami T, Sato Y, Ariga S, et al. Regulation of oxidative stress and inflammation by hepatic adiponectin receptor 2 in an animal model of nonalcoholic steatohepatitis[J]. Int J Clin Exp Pathol, 2010, 3:472-481. https://www.ncbi.nlm.nih.gov/pubmed/20606728 [12] Okada-Iwabu M, Yamauchi T, Iwabu M, et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity[J]. Nature, 2013, 503:493-499. doi: 10.1038/nature12656 [13] Mootha VK, Handschin C, Arlow D, et al. Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle[J]. Proc Natl Acad Sci U S A, 2004, 101:6570-6575. doi: 10.1073/pnas.0401401101 [14] Lee J. Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes[J]. Arch Pharm Res, 2013, 36:208-222. doi: 10.1007/s12272-013-0023-8
点击查看大图
计量
- 文章访问数: 100
- HTML全文浏览量: 34
- PDF下载量: 5
- 被引次数: 0